IRD

Opus Genetics INC

+$148.3M

Net Activity

Institutions Holding

79

Popularity Rank

#4983

Avg Weight

0.51%

Total Value

$204.3M

Ownership Trend

79 institutions currently hold IRD, with 41 net buyers and 22 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Majority Increased

Based on recent trading activity

Net Selling Institutions

22

Net Buying Institutions

41

Key Holders

View all 79 holding institutions

Quarterly Activity

Recent Activity

+$135.0M

Total Buy Value

$25.0M

Total Sell Value

New buy25
Trim16
Add16
Sold out6

41

Net Buyers

22

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding OPUS GENETICS INC (IRD)?
Major stakeholders currently include Caligan Partners LP ($27.6M), Adage Capital Partners Gp, L.l.c. ($27.4M), BIOS Capital Management, LP ($16.8M). Based on the latest 13F filings, there are a total of 79 tracked investment funds and institutions maintaining positions in IRD.
What is the overall institutional sentiment toward IRD recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $148.3M, driven by 41 managers accumulating shares while 22 reduced their exposure.
Which institutions have been selling or reducing their IRD positions?
In the latest period, 16 funds trimmed their holdings, and 6 managers completely exited their positions. The aggregate reported sell value was $25.0M.
Are there any notable investors adding IRD to their portfolios?
Yes, buying activity remains notable. 25 institutions opened new positions in {ticker}, and 16 existing holders added to their shares. The total reported buy value for the quarter amounted to $135.0M.

Related Stocks